Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

253 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.
Mittendorf EA, Storrer CE, Shriver CD, Ponniah S, Peoples GE. Mittendorf EA, et al. Ann Surg Oncol. 2006 Aug;13(8):1085-98. doi: 10.1245/ASO.2006.03.069. Epub 2006 Jul 24. Ann Surg Oncol. 2006. PMID: 16865596 Clinical Trial.
Parathyroid carcinoma.
Mittendorf EA, McHenry CR. Mittendorf EA, et al. J Surg Oncol. 2005 Mar 1;89(3):136-42. doi: 10.1002/jso.20182. J Surg Oncol. 2005. PMID: 15719375 Review.
Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides.
Mittendorf EA, Storrer CE, Shriver CD, Ponniah S, Peoples GE. Mittendorf EA, et al. Breast Cancer Res Treat. 2005 Jul;92(1):85-93. doi: 10.1007/s10549-005-0988-1. Breast Cancer Res Treat. 2005. PMID: 15980996
Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer.
Mittendorf EA, Gurney JM, Storrer CE, Shriver CD, Ponniah S, Peoples GE. Mittendorf EA, et al. Surgery. 2006 Mar;139(3):407-18. doi: 10.1016/j.surg.2005.06.059. Surgery. 2006. PMID: 16546506
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
Mittendorf EA, Storrer CE, Foley RJ, Harris K, Jama Y, Shriver CD, Ponniah S, Peoples GE. Mittendorf EA, et al. Cancer. 2006 Jun 1;106(11):2309-17. doi: 10.1002/cncr.21849. Cancer. 2006. PMID: 16596621 Clinical Trial.
Breast cancer vaccines: promise for the future or pipe dream?
Mittendorf EA, Peoples GE, Singletary SE. Mittendorf EA, et al. Cancer. 2007 Oct 15;110(8):1677-86. doi: 10.1002/cncr.22978. Cancer. 2007. PMID: 17763371 Review.
Satisfaction with breast cancer screening and future screening participation.
Stojadinovic A, Henry LR, Peoples GE, Mittendorf EA, Lenington S, Nissan A, Shriver CD. Stojadinovic A, et al. Among authors: mittendorf ea. Med Sci Monit. 2007 Oct;13(10):CR422-9. Med Sci Monit. 2007. PMID: 17901848
Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
Stojadinovic A, Mittendorf EA, Holmes JP, Amin A, Hueman MT, Ponniah S, Peoples GE. Stojadinovic A, et al. Among authors: mittendorf ea. Ann Surg Oncol. 2007 Dec;14(12):3359-68. doi: 10.1245/s10434-007-9538-x. Epub 2007 Sep 29. Ann Surg Oncol. 2007. PMID: 17906897
Electrical impedance scanning as a new breast cancer risk stratification tool for young women.
Stojadinovic A, Nissan A, Shriver CD, Mittendorf EA, Akin MD, Dickerson V, Lenington S, Platt LD, Stavros T, Goldstein SR, Moskovitz O, Gallimidi Z, Fields SI, Yeshaya A, Allweis TM, Manassa R, Pappo I, Ginor RX, D'Agostino RB, Gur D. Stojadinovic A, et al. Among authors: mittendorf ea. J Surg Oncol. 2008 Feb 1;97(2):112-20. doi: 10.1002/jso.20931. J Surg Oncol. 2008. PMID: 18050282 Clinical Trial.
Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
Peoples GE, Holmes JP, Hueman MT, Mittendorf EA, Amin A, Khoo S, Dehqanzada ZA, Gurney JM, Woll MM, Ryan GB, Storrer CE, Craig D, Ioannides CG, Ponniah S. Peoples GE, et al. Among authors: mittendorf ea. Clin Cancer Res. 2008 Feb 1;14(3):797-803. doi: 10.1158/1078-0432.CCR-07-1448. Clin Cancer Res. 2008. PMID: 18245541 Clinical Trial.
253 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page